News | January 19, 2015

Computerized diagnostic tool improves identification of cancerous and pre-cancerous cervical conditions

DySIS Medical, DySIS Advanced Cervical Imaging System, cancer, women's health

Image courtesy of DySIS Medical


January 19, 2015 — A new computerized diagnostic tool designed to assist in the early detection of cancerous and pre-cancerous cervical lesions, called DySIS (Dynamic Spectral Imaging System) Advanced Cervical Imaging System, is making its U.S. debut after undergoing extensive testing and review in Europe.

Endorsed by the U.K. National Institute of Health and Care Excellence, the new U.S. Food and Drug Administration (FDA)-cleared medical device is being praised by physicians for its ability to help identify abnormalities on the cervix, which can sometimes escape detection during a standard colposcopy. 

Colposcopy is a diagnostic exam, usually following an abnormal Pap smear, in which a doctor applies a special solution to the cervix and peers into a binocular viewer called a colposcope to look for areas that turn white, indicating abnormal cells and that a cervical biopsy may be needed.

"The DySIS system is a next generation colposcope, offering important advancements that improve the examination procedure for both doctors and patients," said Christopher G. Olson, M.D., of Women's Center for Health in Naperville, one of the first OB/GYN practices in the United States to offer the new computer-assisted screening device.

The DySIS Advanced Cervical Imaging System is used by the examining physician as follows:
 

  • A high-resolution digital image of the cervix is displayed on the DySIS touchscreen to allow normal assessment of the cervical area. Image color, brightness, contrast and magnification of the displayed image can be adjusted.
  • Acetic acid, which turns abnormal cervical cells white, is applied to the surface of the cervix by the physician via a built-in syringe with a diffuser for instant homogenized coverage over the cervix.
  • The operator uses the touchscreen interface to conduct a standard colposcopic examination while DySIS measures the acetowhitening effect. Meanwhile, DySIS uses Dynamic Spectral Imaging to record the entire acetowhitening process.
  • The system then produces a DySISmap Advanced Cervical Scan, which is like a weather map showing the precise areas of the cervix where acetowhitening is most extreme and most likely to contain abnormal cells.
  • The physician refers to the DySISmap and marks biopsy points that may be needed based on the information displayed as well as other examination information.
  • The scanned digital image of the cervix and DySISmap showing acetowhitening and biopsy points are then saved along with patient notes entered via the touchscreen.


Olson says that a traditional colposcopy can often be very frightening for a patient because during the examination they have no idea what the doctor is looking at or thinking.  

"Thirty seconds of silence can seem like five minutes, and a patient's imagination can begin to race as they assume the doctor has discovered the worst," Olson said.  

With the DySIS system, Olson says a patient is able to view what the doctor is viewing in real-time and discuss the meaning of the colorized zones and markings on the DySISmap, enabling the patient to be involved and more at ease during the examination procedure.

"I was skeptical that a computer-generated image could pick up cervical abnormalities better than the naked eye, but I was wrong," Olson said. "On a colposcopic image that appeared normal to me, the DySISmap highlighted two areas of abnormalities revealing cervical dysplasia on biopsy. With the new recommendations to decrease Pap smear frequency, it is even more important that colposcopies miss nothing."

Olson says examinations performed using the DySIS Advanced Cervical Imaging System do not result in any additional out-of-pocket expenses for the patient.

For more information: www.dysismedical.com


Related Content

News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
News | Breast Imaging

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...

Time October 28, 2025
arrow
Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
Subscribe Now